Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Noxopharm Ltd V.NOX


Primary Symbol: NOXOF

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.


OTCPK:NOXOF - Post by User

Post by MrMonkon Sep 26, 2013 7:49pm
149 Views
Post# 21771428

NOX update

NOX updateDrill results are coming soon - should be an NR in the next week or so.  They've only drilled down 600 metres or so and the total depth in the area is 2,000+ metres so there's plenty of gold left to find.  Already a nice deposit and more upside remains.

Three parties are interested in the property and a couple of CDAs have already been signed.  Two are apparently producers but I don't know the full details.  A new deal won't happen overnight - could take a few months or more to put a new deal together on Marban.

Fundamentals still intact.  Frustrating to see this thing at $0.10 but people sell for their reasons, not ours.  Louis James at Casey Research may be doing a write-up soon and an institutional buyer is considering a position.  Longs don't deserve the current predicament but if you believe the story is still there, you'll have to keep holding if you are in a position to do so.

-- MM
<< Previous
Bullboard Posts
Next >>